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Background: Diet is the first line of treatment for elevated cholesterol. High-intensity dietary counseling (≥360
minutes/year of contact with providers) improves blood lipids, but is expensive and unsustainable in the current
healthcare settings. Low-intensity counseling trials (≤ 30 minutes/year) have demonstrated modest diet changes,
but no improvement in lipids. This pilot study evaluated the feasibility and the effects on lipids and diet of a
low-intensity dietary counseling intervention provided by the primary care physician (PCP), in patients at risk for
cardiovascular diseases.
Methods: Six month study with a three month randomized-controlled phase (group A received the intervention,
group B served as controls) followed by three months of intervention in both groups.
Sixty-one adults age 21 to 75 years, with LDL-cholesterol ≥ 3.37 mmol/L, possessing Internet access and active email
accounts were enrolled. Diet was evaluated using the Rate-Your-Plate questionnaire. Dietary counseling was
provided by the PCP during routine office visits, three months apart, using printed educational materials and a
minimally interactive counseling website. Weekly emails were sent reminding participants to use the dietary
counseling resources. The outcomes were changes in LDL-cholesterol, other lipid subclasses, and diet quality.
Results: At month 3, group A (counseling started at month 1) decreased their LDL-cholesterol by −0.23 mmol/L,
(−0.04 to −0.42 mmol/L, P = 0.007) and total cholesterol by −0.26 mmol/L, (−0.05 to −0.47 mmol/L, P = 0.001). At
month 6, total and LDL-cholesterol in group A remained better than in group B (counseling started at month 3).
Diet score in group A improved by 50.3 points (38.4 to 62.2, P < 0.001) at month 3; and increased further by 11.8
(3.5 to 20.0, P = 0.007) at month 6. Group B made the largest improvement in diet at month 6, 55 points (40.0 to
70.1, P < 0.001), after having a small but significant improvement at month 3, 22.3 points (12.9 to 31.7, P < 0.001).
No significant changes occurred in HDL-cholesterol in either group.
Conclusions: A low-intensity dietary counseling provided by the PCP in patients at risk for cardiovascular diseases
produced clinically meaningful improvements in both diet and lipids of magnitude similar to changes reported
with high intensity interventions.
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Approximately 16% of U.S. adults have unhealthy total
cholesterol levels of 5.18 mmol/L or higher [1]. A
sustained reduction of 0.6 mmol/L in total serum chol-
esterol level—an average decrease of 10%—can reduce
coronary heart disease by about 25-30% [2]. Diet is the
first line of treatment for high cholesterol [3]. For adult
patients with hyperlipidemia and other known risk
factors for cardiovascular and diet-related chronic dis-
ease, the current U.S. Preventive Services Task Force
(USPSTF) clinical guidelines recommend high-intensity
(more than 360 minutes/year of contact with providers)
dietary counseling. Intensive counseling could be deli-
vered by primary care clinicians or by referral to other
specialists, such as nutritionists or dietitians [4]. None-
theless, high-intensity and even medium-intensity (>30
and <360 minutes per year) counseling require resources
that may not be available in most primary care settings
in the U.S. Because of this reality, the current guidelines
on dietary counseling for patients with high cholesterol
are an elusive goal in contemporary clinical practice.
Data from the 2010 National Ambulatory Medical Care
Survey show that only 11.7% of visits to primary care
physicians (PCP) included any type of counseling
(provided by the PCP or referred out) for diet or nutri-
tion. This percentage is down from 13.5% in 2006 [5,6].
Trials of low-intensity dietary counseling (≤ 30
minutes/year of provider contact) have found modest
changes in diet, but failed to show improvement in lipid
profiles [7]. Accordingly, this strategy is not currently
recommended for use in clinical practice. While the high
and medium intensity counseling intervention trials
were conducted in subjects with hypercholesterolemia
and other risk for cardiovascular diseases, most studies
of low-intensity dietary counseling interventions were
conducted in the general-risk population. The unse-
lected population, along with other factors related to the
design and delivery of the low-intensity interventions,
may have contributed to the lack of significant impact of
these interventions on cardiovascular risk reduction.
Innovative, time-efficient, and effective low-intensity
strategies for dietary changes are needed, and clinical
trials of these strategies are essential to justify their util-
ity [7]. We hypothesized that a low-intensity dietary
counseling intervention targeting patients with hyper-
cholesterolemia and other cardiovascular risks deli-
verable within the context of a clinical visit would be a
practical and effective option for use in primary care
settings.
To test the feasibility and the effects of this strategy
we designed a low-intensity dietary counseling inter-
vention (LiveWell) to be delivered in the course of a
primary care visits. The LiveWell intervention was
conducted as a pilot study that enrolled patients withdyslipidemia who also scored low on a brief food-
frequency screening questionnaire (Rate-Your -Plate) [8].
The counseling requires only 5–6 minutes of contact
with the provider (in this case the primary care phys-
ician), and can be delivered during a regular office visit
for dyslipidemia. This allows the physician to emphasize
that diet is an integral part of dyslipidemia treatment
and cardiovascular risk reduction. The intervention uses
patient educational materials (paper and web-based) and
weekly no-reply email reminders that prompt patients to
pursue their dietary goals. This article reports the
changes in LDL-cholesterol, other lipid subclasses, and




This was a six month pilot study with a three month
randomized-controlled phase (during which group A
received the intervention, and group B served as
controls) followed by three months of intervention in
both groups. The study was conducted at the University
of Nevada, School of Medicine at Reno, from July 2011
through May 2012. The study used a 1:1 ratio simple
randomization. The subjects’ allocation to groups was
concealed by enclosing the assignments in serially num-
bered, opaque, sealed envelopes. The randomization list
was computer generated. The envelopes were prepared
by a statistician who was not involved with enrollment
or data analysis.
Participants
The population consisted of adults between the ages of
21 to 75 years, who received their health care at one of
the University-affiliated primary care clinics. Eligibility
required documentation of an LDL-cholesterol level of
3.37 mmol/L or higher within the twelve months prior
to enrollment. Potential subjects were also required to
have access to the Internet and an active email account.
The use of lipid lowering drugs was not an exclusion cri-
terion, but patients taking these drugs had to be on the
same medication and dose for at least three months
prior to enrollment, with no changes anticipated for the
duration of the trial. We excluded patients with poorly
controlled diabetes mellitus (defined by HbA1c > 9%),
serum creatinine above 132.6 μmol/L, malignancy, cir-
rhosis, eating disorders, acute coronary syndrome in the
last three months, congestive heart failure NYHA class
III and IV, ongoing warfarin therapy, uncontrolled
hypo- or hyperthyroidism, ongoing weight loss, history
of bariatric surgery, pregnant women, and patients
who scored more than 250 (on a scale of 100 to 300)
on a food frequency questionnaire administered on
the day of enrollment. Patients with a history of
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used the Friedewald formula [LDL-C =Total cholesterol-
(TGs/5 +HDL-C)] to calculate LDL-cholesterol levels. The
study was conducted under the guidelines of the Dec-
laration of Helsinki. The University of Nevada Institu-
tional Review Board reviewed and approved the protocol.
All subjects provided written informed consent before
participation.Study protocol
Patients who met the LDL-cholesterol inclusion criteria
were sent a letter to inform them about the study.
Patients who responded to the letter were further
assessed for the eligibility. The outline of the study pro-
cedures is shown in Figure 1.Visit #0 - Eligible patients underwent dietary screening usin
questionnaire. Patients with a diet score less than 250 were
scheduled for a fasting lipid panel and for Visit#1 within two
only to patients who scored more than 250, as they no long
Group A
Visit #1 – Weight, height, blood pressure and pulse were measured
beginning of the visit. During a “focused office visit” the primary care
(PCP) reviewed the results of the fasting lipid panel and diet assessm
patient emphasizing the role of diet on lipids and cardiac health. The
provided the patient with written educational materials and access to
counseling website. Fasting lab and Visit#2 were scheduled for three
Weekly automatic emails sent to patient reminding to visit the counse
Visit #2 - Weight, blood pressure and pulse were measured 
at the beginning of the visit. During a “focused office visit” the 
PCP reviewed the results of the new fasting lipid panel and 
diet assessment with the patient, emphasizing the role of diet 
on lipids and cardiac health. Fasting lab and Visit#3 were 
scheduled for three months.
Weekly automatic emails sent to patient
Visit #3 – Weight, blood pressure and pulse were m
office visit” the PCP reviewed the results of the new
Figure 1 The outline of the study procedures.The dietary assessment
Diet was assessed using a version of the Rate-Your-Plate
(RYP) questionnaire modified for web-based use. The
RYP was developed by Gans et al. in the late 1980s (peri-
odically updated thereafter) as a paper-based, self-
administered assessment tool of the eating-pattern that
would allow a quick evaluation of dietary habits related
to heart disease prevention [8,9]. This tool has been
validated and shown to be an effective part of a program
to lower patient’s cholesterol [10]. We used a modified
version of the 2009 edition which has 25 questions. The
answers in this questionnaire are displayed in three
columns: column A includes the least “heart-healthy”
choices; column C includes the most “heart-healthy”
choices; and Column B is a “middle ground”. The RYP
assigns points to these answers (1 point for answers ing a modified version of the Rate Your Plate 
 randomized to one of the two groups and were 
 weeks. The results of the diet test were reveled 








Visit #1: Weight, height, blood pressure 
and pulse were measured at the 
beginning of the visit. No blood test or 
diet questionnaire results were reviewed 
with the patient. Fasting lab and Visit#2 
were scheduled for three3 months.
ling website
Visit #2 - Weight, blood pressure and pulse were measured at 
the beginning of the visit. During a “focused office visit” the 
PCP reviewed the results of the two fasting lipid panels and 
diet assessments with the patient, emphasizing the role of diet 
on lipids and cardiac health. The PCP provided the patient 
with written educational materials and access to the 
counseling website. Fasting lab and Visit#3 were scheduled 
for three months.
reminding to visit the counseling website
easured at the beginning of the visit. During a “focused 
fasting lipid panel and diet assessment with the patient.
Diet score from100 to 174 =  
POOR diet quality 
Diet score from 250 to 274 =  
GOOD diet quality 
Diet score from 175 to 249 =  
FAIR diet quality  
Diet score from 275 to 300 =  
VERY GOOD diet quality 
Figure 2 The computer generated display of the “Rate your
Plate” Questionnaire Results.
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column B and C, respectively. The sum of all the points
produces an overall total diet score (on a scale of 25 to
75). This overall diet score is separated into tertiles that
define three levels of overall diet quality: A = least heart
healthy, C = heart healthy and B = in -between diet
quality.
While the RYP was the most suitable questionnaire
that we could find to assess diet behavior in the primary
care setting, the time needed to review each of the 25
items with the patient was too long to fit within a
routine 15 minute physician office visit. In addition, the
display of results in the original does not allow for easy
spotting of “problem” items. To overcome these limita-
tions we modified the display of the results. First, we
consolidated the results of the 25 items into 12 “diet
categories” by combining the items that would be natur-
ally addressed together (e.g., items reflecting meat
quality and meat portion size) and averaging the points
of the corresponding items for each diet category. The
RYP 25 to 75 scale was changed to a 100 to 300 scale
that avoided decimal scores upon averaging. As men-
tioned, the original RYP categorizes the total diet score
into three levels: A, B, and C. Using this scale, a patient’s
overall diet could be classified as C = heart healthy while
having a significant number of items answered as B. As
our goal was to motivate patients to reach the best diet
to lower cholesterol, we differentiated between the lower
and the upper halves of the C = heart healthy overall diet
scores and obtained four diet quality levels (A, B, C1
and C2). Taking advantage of computer graphics, we also
created a color coded display of the results with red
(poor diet) for A, yellow (fair diet) for B, blue (good diet)
for C1 and green (very good diet) for C2 diet choices.
The color coded display and the shorter list (12 diet
categories instead of 25 items) provided an easy to inter-
pret “snap-shot” of the patient’s diet (Figure 2). These
innovations were possible by translating the paper ver-
sion of the RYP into a self-administered computer-based
version, which the patients could complete while in the
physician’s office waiting room or at home. For this pilot
study we administered the questionnaire at the study site
to observe whether patients had questions while taking
the test, and to monitor for technical difficulties.
The counseling materials
We used paper-based patient educational materials and
a secure counseling website. The paper-based patient
educational materials consisted of a book specially
written for this intervention. The book has 98 pages,
with an average of 320 words per page, typed in size 11
font, with line spacing of 1.15. The average Flesch–
Kincaid reading ease score of the book is 60, which
should be easily understandable by 13- to 15-year-oldstudents [11]. Figure 3 displays the Table of Contents. In
addition to general information about the effect of diet,
body weight and physical activity on cholesterol, the
book has 12 sections corresponding to the 12 diet
categories of the questionnaire report. The counseling
website contains the same educational materials but
adds an interactive, personal, password-protected section
that includes the results of the patient’s diet test, their
personal diet goals and provides tracking of their dietary
changes. Access to the website was controlled by the
website administrator (in this case the study investiga-
tor) in order to preserve the design of the study. The
interactive section of the website allowed patients to set
goals to improve their diet category scores. Once a
patient selected one or more diet categories they wanted
to improve, the interactive system would display a list of
specific steps to achieve those goals (i.e.: 1- Trim all
visible fat on the meat you eat; 2 - Use only 95% or
leaner ground meet; 3 – Limit the portion size to 3–4 oz
of meat per meal; etc.). Points were assigned to each
step, and the total cumulative goal was computed and
displayed. Completion of each step earned the patient
one point. If the patient had not yet taken a particular
step, but was planning to start doing it in the near
future, a value of 0.5 points was assigned. Steps that the
About Your Cholesterol page  1
Food Components and Your Cholesterol 
Bad Components:
Trans fats page   6
Saturated fats page 12
Dietary cholesterol page 17
Added sugars page 19
Good Components: 
Unsaturated fats (MUFA, PUFA, Omega 3) page 23
Dietary fiber page 28
How to make good choices when eating
Meat page 34
Chicken and Turkey page 36
Fish and Shellfish page 38
Milk, Dairy and Eggs page 42
Grains page 44
Fruits and Vegetables page 48
Cooking Methods page 55




Dining out and Frozen Meals page 74
Dietary Supplements and Cholesterol page 76
Physical Activity and Cholesterol page 83
Body Weight and Cholesterol page 88
How to Read Food Labels page 95
Figure 3 The table of contents for patient’s book on healthy diet and cholesterol.
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stopped, were assigned a zero value. Weekly automatic,
no-reply email reminders were sent to patients encour-
aging them to access the website, take the steps required
and maximize their points to improve their diet. No add-
itional patient counseling support (in person, by phone or
email) was provided.
Data collection
At baseline, data were collected on demographic charac-
teristics (age, sex, years of education, use of Internet),
height, weight, blood pressure, smoking, alcohol intake,
cardio-metabolic past medical history, use of medica-
tions, diet assessment scores, and laboratory values.
Weight was measured using a calibrated electronic scale
and was recorded in pounds (to the nearest half pound).
Height was measured using a stadiometer affixed to the
wall, and was recorded in inches (to the nearest quarter
inch). These measurements were obtained with subjects
barefoot and wearing light garments. Body mass index
(BMI) was calculated from these measurements as
weight in kg/height in m2. Blood pressure was measured
using a calibrated automatic sphygmomanometer, after
the subjects were seated for five minutes. Blood samples
for chemistries were drawn after a 12 hour overnight
fast. The lipid panel was tested by LipoScience Inc.,
(Raleigh, NC) using nuclear magnetic resonance spectros-
copy (NMR) to assess the lipid subclass particle counts
and sizes, and standard chemical methods (BeckmanCoulter and performed on Olympus AU Systems) to
measure total cholesterol, HDL-cholesterol and triglycer-
ides. LDL-cholesterol was calculated using the Friedewald
formula [LDL-C = Total cholesterol-(TGs/5 +HDL-C)].
Fasting blood glucose was measured using a commercial
enzymatic assay at the local LabCorp facility. Framingham
risk score was calculated by using the regression equation
from D’Agostino 2008 [12].
Statistical methods
The sample size was chosen on the theoretical basis that
at least 30 subjects per treatment group is reasonable for
use of a parametric two-sample t-test to estimate treat-
ment differences, assuming a normal distribution of the
outcome measures [13].
Statistical analyses were conducted using SPSS for
Windows version 12.0 (SPSS Inc. SPSS for Windows,
Release 12.0.1. Chicago, IL, 2003). All p-values were
two-tailed with p < 0.05 required for statistical sig-
nificance. Frequencies were obtained for categorical
variables. Differences between groups were tested using
Chi-squared statistics in the Crosstabs procedure. For
continuous variables, the UniANOVA procedure was
used to compute means at baseline by group and to test
between group differences at baseline without consi-
deration of covariates. Correlations between the two
overall diet scores (original and modified) were com-
puted using the Partial Corr procedure with adjustment
for age, sex, education in years and baseline BMI.
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between visits were assessed using the ANOVA proce-
dure. The GLM procedure was used to perform repeated
measures ANOVA with analyses stratified by treatment
group to assess the changes in outcome variables
between study visits 1 and 2, visits 2 and 3, and visits 1
and 3. This procedure reflected the study design under
which Group A was expected to make significant
changes between visit 1 and visit 2, then preserve or
increase those changes at visit 3, while Group B was
expected to make modest changes between visit 1 and
visit 2, but greater changes between visit 2 and visit 3.
These models were adjusted for age, sex, education in
years and baseline BMI. For these models we report
mean changes between visits, with 95% confidence inter-
vals. The analysis was done by original assigned groups.
The primary end points were the changes in LDL-
cholesterol across time in the two groups. The secondaryAssessed for elig
records of LD
3 months data analysis 
(n=31)
6 months data analysis 
(n=29)
Lost to follow-up (n=3)
1 subject did not complete the 3 
month visit (left town due to illness 
in the family)
2 subjects did not complete the 6 
month visit (one had urgent surgery 
with long hospitalization; one got a 
new job and felt “too busy to 
continue”)
Allocated to group A (n=32)
Rando
Excluded from analysis 
due lost to follow-up at 3 
months (n=1)
Excluded from analysis 




Figure 4 Study flow diagram.outcomes were changes in total cholesterol, HDL-
cholesterol, triglycerides and diet score across time.
Results
Patients
Sixty-one subjects were enrolled and randomized to
group A (N = 32) and B (N = 29); 95% completed the
study (Figure 4). Three participants were lost to follow-
up: one participant (group A) dropped from the study at
visit 2 (had blood labs done but did not complete the
clinical encounter) due to a family emergency; and two
participants (group A) did not complete any elements of
visit 3 (one was hospitalized for non-elective surgery and
was unable to return in time to complete the study, and
the other dropped out because he “got too busy”). Base-
line characteristics by study group are presented in
Table 1. Except for race, there were no significant differ-
ences between groups in baseline characteristics. Theibility based on medical 
L-Cholesterol (n=90)
Excluded (n=8)
Not meeting the rest of inclusion-
exclusion criteria (n=7)
Declined to participate (n=1)
Lost to follow-up
(n=0)
Allocated to Group B (n=29)
3 months data analysis 
(n=29)
6 months data analysis 
(n=29)
mized (n=61)
ded to the “invitation letter”
ed for eligibility (n=69)






Age (yr) 52.3 (±12.8) 52.1 (±12.7) 0.81
Sex (Female) 25 (78.1%) 21 (72.4) 0.80
Race
White 22 (68.8%) 27 (93.1)
Hispanic 7 (21.9%) 2 (6.9%) 0.048*
Asian 3 (9.3%) 0
Years of education (yr) 14.7 (±2.6) 15.4 (±2.4) 0.39
BMI (kg/m2) 30.6 (±5.6) 31.4 (±7.1) 0.70
Internet use
4-7 days/week 25 (78.1%) 26 (89.7%) 0.25
1-3 days/week 4 (12.5%) 0
< 1 day/week 3 (9.4%) 3 (10.3%)
Past medical hystoryb
A 6 (18.8%) 9 (31%)
A,B 1 (3.1%) 0
A,C 1 (3.1%) 0 0.56
A,D 1 (3.1%) 0
B 2 (6.2%) 1 (3.4%)
E 21 (65.6%) 19 (65.5%)
Statins use (yes) 4 (12.5%) 1 (3.4%) 0.20
Lipid lowering dietary
supplements 13 (40.6%) 6 (21%) 0.093
Yes
Alcohol intake (drinks/day)
None 21 (65.6%) 18 (62.1%)
Less than one 4 (12.5%) 5 (17.2%)
One 7 (21.9%) 4 (13.7%) 0.78
Two 0 2 (6.9%)
More than two 0 0
Smoking (yes) 2 (6%) 3 (10%) 0.56
Systolic blood pressure (mmHg) 123 (±12) 124 (±14) 0.92
Diastolic blood pressure (mmHg) 78.2 (±12) 78.4 (±15) 0.55
Diet quality (new format)
Very good 0 0
Good 0 1 (3.4%) 0.10
Fair 29 (90.6%) 20 (69.0%)
Poor 3 (9.4%) 8 (27.6%)
Diet quality (old format)
A-Good 2 (6.3%) 3 (10.3%) 0.12
B-Fair 27 (84.4%) 19 (65.5%)
C-Poor 3 (9.4) 7 (24.1%)
Diet score (100 to 300 scale) 201 (±32) 193 (±35) 0.36
Diet score (25 to 75 scale) 50 (±7.5) 48 (±8) 0.42
Table 1 Characteristics of the patients at baselinea
(Continued)
LDL-particles number 2060 (±559) 2032 (±505) 0.82
Total cholesterol (mmol/L) 5.62 (±0.74) 5.78 (±0.56) 0.42
LDL-cholesterol (mmol/L) 3.31 (±0.84) 3.37 (±0.49) 0.71
HDL-cholesterol (mmol/L) 1.38 (±0.30) 1.46 (±0.32) 0.30
Total/HDL-cholesterol ratio 4.07 (±0.99) 4.17 (±0.99) 0.85
Triglycerides (mmol/L)) 2.05 (±1.55) 2.06 (±0.99) 0.92
Fasting Glucose (mmol/L) 5.29 (±0.84) 5.16 (±0.56) 0.52
aContinuous variables are given as mean and ± SD; categorical and ordinal
variables data are given as number and (%).
bA = Hypertension, B = diabetes mellitus type 2, C = coronary heart disease,
D = cerebo-vascular accident, E = no past medical history of
cardio-metabolic diseases.
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participants were white and female. The average BMI
was 31. Most patients used the Internet at least 4 days a
week. The average diet score (on the original RYP scale
of 25 to 75, with 25 being the worst) was 50 (95% CI,
42.5 to 57.5) in group A, and 48 (40 to 56) in group B,
P = 0.42; the corresponding modified diet scores were 201
and 193. The average baseline LDL-cholesterol in was
3.31 mmol/L (2.48 to 4.14 mmol/L) in Group A, and 3.37
mmol/L (2.87 to 3.86 mmol/L) in Group B, P = 0.71.
Diet
There was a very strong correlation between the
“original” and “modified” diet scores, r = 0.967, p =
0.0005. Preliminary analyses showed the relationship to
be linear, with both variables normally distributed, as
assessed by the Shapiro-Wilk test (P >0.05), and there
were no outliers.
Both groups improved their diet across time (Table 2).
As expected, participants in group A (counseling started
at visit 1), made the largest improvements in their over-
all diet scores between visit 1 and visit 2 (3 months
later), then retained or continued to improve their diet
at visit 3 (6 months from visit 1). The average diet score
in group A at visit 1 was 203, (191 to 215) with an
improvement of 50.3 (38.4 to 62.2, P < 0.001) at visit 2;
and a further increase of 11.8 (3.5 to 20.0, P = 0.007) at
visit 3. Also as predicted, Group B (counseling started at
visit 2) made the largest improvement in their diet
between visit 2 and visit 3, 55.0 (40.0 to 70.1, P < 0.001).
Group B also had a small, but statistically significant
improvement in overall diet score between visits 1 and 2;
22.3 (12.9 to 31.7, P < 0.001).
Figure 5 displays the percentages for diet quality
(poor, fair, good, and very good) in the two groups at
baseline, three, and six months. At baseline there were
no statistically significant differences between the
groups, χ2(2) = 4.7, P = 0.09. At three months, diet
quality in Group A improved significantly compared
Table 2 The diet, lipid profile, BMI, and framingham risk score across time in the two groups (Models adjusted for age,
sex, education, and baseline BMI)
Outcome variable Time Group A Group B
Adjusted means (95% CI)
and changes
in adjusted means (95% CI)
P values Adjusted means (95% CI)
and changes
in adjusted means (95% CI)
P values
Overall Diet Score
(on the original scale of 25 to75)
V1 50.9 ( 48.1 to 53.8) 48.4 (45. 3 to 51.4)
V2 62.9 (60.6 to 65.1) 53.0 (49.6 to 56.4)
V3 65.2 (60.6 to 66.9) 66.1 (64.0 to 68.2)
V2 vs.V1 11.99 (9.2 to 14.7) P < 0.001 4.7 (2.4 to 6.9) P < 0.001
V3 vs.V2 2 (0.1 to 4.4) P < 0.001 13.1 (9.5 to 16.7) P < 0.001
V3 vs.V1 14.2 (11.1 to 17.4) P = 0.038 17.8 (14.4 to 21.1) P < 0.001
Overall Diet Score
(on the modified scale of 100 to 300)
V1 203 (191–215) 193 (180 to 206)
V2 253 (244–263) 215 (201 to 230)
V3 265 (258–272) 270 (262 to 278)
V2 vs.V1 50.3 (38.4 to 62.2) P < 0.001 22.3 (12.9 to 31.7) P < 0.001
V3 vs.V2 11.8 (3.5 to 20.0) P = 0.007 55.0 (40.0 to 70.1) P < 0.001
V3 vs.V1 62.1 (50.1 to 74.1 P < 0.001 77.3 (63.5 -91.2) P < 0.001
BMI (kg/m2) V1 30.4 (28.4 to 32.4) 31.2 (28.4 to 34.1)
V2 29.9 (27.9 to 31.9) 31.1 928.4 to33.90
V3 29.8 (27.7 to 31.8) 30.3 (27.7 to 33.0)
V2 vs.V1 −0.5 (−0.1 to −0.8) P = 0.01 −0.1 (−0.4 to 0.2) P = 0.55
V3 vs.V2 −0.2 (−.1.1 to 0.1) P = 0.12 −0.8 (−0.4 to −1.2) P = 0.001
V3 vs.V1 −0.6 (−0.2 to −1.1) P = 0.006 −0.9 (−0.4 to −1.4) P < 0.001
LDL-Particles
(Number)
V1 2048.3 (1861.8 to 2234.8) 2032.3 (1838.4 to 226.3)
V2 1837.5 (1575.3 to 1999.7) 2114.6 (1941.9 to 2287.2)
V3 1772.7 (1597.5 to1947.8) 1912.7 (1752.5 to 2072.8)
V2 vs.V1 −210.8 (−371.50 to −50.0) P = 0.012 82.2 (−65.0 to 229.5) P = 0.26
V3 vs.V2 −64.8 (−180.4 to 50.7) P = 0.26 −201.9 (−315.4 to −88.5) P = 0.001
V3 vs.V1 −275.6 ( −411.8 to −139.4) P < 0.001 −119.7 (−241.3 to 1.9) P = 0.053
LDL-Cholesterol
(mmol/L)
V1 3.28 (2.96 to 3.60) 3.44 (3.26 to 3.61)
V2 3.14 (2.90 to 3.38) 3.56 (3.26 to 3.75)
V3 2.96 (2.67 to 3.25) 3.44 (3.14 to 3.73)
V2 vs.V1 −0.14 (−0.43 to 0.15) P = 0.38 0.12 (−0.04 to 0.29) P = 0.14
V3 vs.V2 −0.18 (−0.01 to −0.36) P = 0.046 −0.12 (−0.38 to 0.14) P = 0.40
V3 vs.V1 −0.32 (−0.06 to −0.58) P = 0.016 0.001 (−0.27 to 0.28) P = 0.90
HDL-Cholesterol
(mmol/L)
V1 1.36 (1.26 to 1.45) 1.46 (1.36 to 1.56)
V2 1.42 (1.30 to 1.54) 1.46 (1.36 to 1.55)
V3 1.38 (1.27 to 1.49) 1.44 (1.34 to 1.53)
V2 vs.V1 0.06 (−0.02 to 0.15) P = 0.14 −0.01 (−0.06 to 0.05) P = 0.82
V3 vs.V2 −0.04 (−0.03 to 0.05) P = 0.28 −0.02 (−0.08 to 0.05) P = 0.54
V3 vs.V2 0.02 (−0.03 to 0.08) P = 0.37 −0.03 (−0.10 to 0.05) P = 0.47
Triglycerides
(mmol/L)
V1 2.06 (1.58 to 2.54) 2.06 (1.68 to 2.44)
V2 1.68 (1.41 to 1.95) 1.95 (1.53 to 2.37)
V3 1.85 (1.51 to 2.19) 1.65 (1.26 to 2.03)
V2 vs.V1 −0.38 (0.76 to 0.16) P = 0.055 −0.11 (−0.27 to 0.05) P = 0.16
V3 vs.V2 0.17 (−0.16 to 0.50) P = 0.30 −0.30 (−0.63 to 0.02) P = 0.07
V3 vs.V1 −0.21 (−0.65 to 0.24) P = 0.34 −0.41 (−0.76 to −0.06) P = 0.03
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Table 2 The diet, lipid profile, BMI, and framingham risk score across time in the two groups (Models adjusted for age,
sex, education, and baseline BMI) (Continued)
Total Cholesterol
(mmol/L)
V1 5.60 (5.34 to 5.85) 5.78 (5.58 to 5.97)
V2 5.35 (5.06 to 5.66) 5.87 (5.64 to 6.10)
V3 5.15 (4.83 to 5.46) 5.60 (5.27 to 5.92)
V2 vs.V1 −0.24 (−0.49.1 to 0.01) P = 0.06 0.10 (−0.09 to 0.28) P = 0.30
V3 vs.V2 −0.21 (−0.44 to 0.02) P = 0.07 −0.27(−0.52 to −0.03) P = 0.03
V3 vs.V1 −0.45 (−0.65 to −0.25 P = 0.001 −0.18 (−0.49 to 0.15) P = 0.25
Framingham risk
score (%)
V1 9.2 (7.0 to 11.4) 8.4 (7.0 to 9.8)
V2 8.3 (6.3 to10.3) 7.8 (6.5 to 9.1)
V3 6.9 (5.1 to 8.7) 7.1 (6.0 to8.2)
V2 vs.V1 −0.9 (−1.5 to-0.3) P = 0.005 −0.6 (−1.5to 0.3) P = 0.19
V3 vs.V2 −1.4 (−2.5 to −0.2) P = 0.03 −0.7 (−1.2 to −0.2 P = 0.014
V3 vs.V1 −2.3 (−3.6 to −0.9) P = 0.002 –1.3 (−2.1 to −0.5) P = 0.003
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participants with poor diet in group A; 16.1% of them
(vs. 3.4% in group B) achieved a very good diet; and
41.9% of group A had a good diet compared to 17.2%
in group B. As predicted, at six months (3 months after
dietary counseling was initiated in group B), there was no
statistically significant difference between the groups,
χ2(2) = 1.2, P = 0.5: there were no participants with poor
diet scores in either of the two groups, and the percent-
age of participants that scored a very good diet was
37.9% in group A and 48.3% in group B.
Lipids
As shown in Table 2, in group A changes from baseline
in total and LDL-cholesterol were not significant at visit
2, but did become statistically significant at visit 3: total
cholesterol −0.45 mmol/L (−0.65 to −0.25 mmol/L,
P = 0.001) and LDL-cholesterol −0.32 mmol/L (−0.06
to −0.58 mmol/L, P = 0.016). In contrast, LDL-particle
count decreased significantly at visit 2, -210.8 (−371.50
to −50.0, P = 0.012), and this improvement was
maintained at visit 3. In Group B, which had the start of
dietary counseling delayed to visit 2, the changes between
visit 2 and visit 3 were statistically significant for LDL-
particle number, -201.9 (−315.4 to −88.5, P =0.001) and for
total cholesterol, -0.27 mmol/L (−0.52 to −0.03 mmol/L,
P = 0.03), but the change in LDL-cholesterol was not statis-
tically significant −0.12 mmol/L (95% CI, -0.38 mmol/L to
0.14 mmol/L), P = 0.4. Adjusted means for total-cholesterol,
LDL-cholesterol and LDL-particle count at visit 2 were sig-
nificantly better in Group A than Group B. Compared with
group B, group A decreased their LDL-particle count by
an average of −213.9, (−70 to – 357, P = 0.001; LDL-
cholesterol by an average of −0.23 mmol/L, (−0.04 to −0.42
mmol/L, P = 0.007 and total cholesterol by −0.26 mmol/L,
(−0.05 to −0.47 mmol/L, P = 0.001). At the six month visit,
changes in group A remained better than those in group Bfor total and LDL-cholesterol, while there was no statisti-
cally significant difference between the groups in LDL-
particle count.
In contrast to the significant changes in total and
LDL-cholesterol, there were no significant changes over
time in HDL-cholesterol in either group, and the triglyc-
erides showed significant improvement only in group B
at visit 3.
Body mass index declined at six months in Group A by
an average of −0.6 kg/m2 (−0.2 to −1.1 kg/m2), P = 0.006,
and in group B by −0.9 kg/m2 (−0.4 to −1.4 kg/m2),
P < 0.001. The 10 years Framingham risk score showed
also a small, but statistically significant improvement
across time in the two groups, more prominent in group
A than Group B. At six months patients in Group A lower
there their risk score by an average of 2.3% (0.9% to 3.6%)
and Group B by 1.3% (0.5% to 2.1%).
Discussion
A meta-analysis performed in 2010 to assist the U.S.
Preventive Services Task Force in formulating recom-
mendations on physical activity and dietary counseling
to prevent cardiovascular disease found that high-
intensity counseling intervention on diet or combined
lifestyle counseling decreased total cholesterol by 0.17
mmol/L (0.09 to 0.25 mmol/L) and LDL-cholesterol by
0.13 mmol/L, (2.39 to 0.21 mmol/L) [7]. The same
meta-analysis found no statistically significant changes
in HDL- cholesterol and triglycerides. High-intensity
dietary counseling, with or without physical activity
counseling, also resulted in changes of −0.3 to −0.7 kg/m2
in BMI. The low-intensity trials included in the above
meta-analysis failed to show any benefits in the lipid
profile, although there was some improvement in the
healthful eating behavior.
Our low intensity dietary counseling intervention





















































































Diet Quality at 6 Months
Chi-square (2df)=1.2
P=0.55
Group A Group B
Figure 5 The percentages of diet quality categories (poor, fair,
good and very good) in the two groups at: baseline (v1), three
months (v2) and six months (v3).
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those of high intensity intervention trials in both diet
and lipids, and BMI. As hypothesized, statistically signifi-
cant changes in diet were achieved in each group after
the intervention. In group A, which started the interven-
tion at visit 1, the most prominent improvement in diet
was seen at visit 2, and continued to improve at visit 3.
For Group B, which started the intervention at visit 2,
the most prominent improvement occurred at visit 3.
Interestingly, group B showed a smaller, but statisticallysignificant improvement in diet at visit 2 as well. This
could be the result of motivated patients who were inter-
ested in participating in lifestyles changes study, or could
be due to a Hawthorn effect, both of which could under-
estimate the magnitude of the effect of the counseling
intervention. Lipid levels (especially total and LDL–chol-
esterol) are known to have seasonal variations, with
values being approximately 0.18 mmol/L higher in the
winter than in the summer [14,15]. Participants in this
study had baseline lipids drawn in July-September; the 3
month follow-up labs were drawn during November-
January, and the six month follow up labs were drawn
during February- May. Consistent with an effect of this
nature, in group B there was a trend for higher total and
LDL-cholesterol at visit 2 (occurring in winter and
before they were exposed to the intervention) compared
with baseline. The changes in these lipid fractions
between the groups at visit 3 are the least biased by
season since those assessments were done contempora-
neously and this visit was conducted between February
and May when dietary distortions due to the holidays
were not a factor. Accordingly, these results represent
the most accurate test of the effect of dietary counseling
on total and LDL–cholesterol and showed significantly
better outcomes in Group A.
While this was not a weight loss intervention, we did
see a small, but statistically significant decrease in BMI
across time in both groups. We also noticed a small and
statistical significant improvement in the 10 years
Framingham risk score. While these results are statisti-
cally significant they may not be clinically relevant in
our opinion, due to their small magnitude.
Physicians are perceived by patients as the most
credible source of health information [16]. Patients value
the physicians’ advice, and are motivated to act on it
[17]. Nonetheless, the reality is that during a routine
office visit, the physician has only few minutes to assess
a medical problem (reviewing a brief history and few
diagnostic tests), and to initiate treatment (writing a
drug prescription). This leaves very little time for dietary
counseling [18,19]. In addition, some studies have found
that physicians do not posses adequate nutritional know-
ledge to deliver efficient dietary counseling or they may
lack confidence in doing so [20,21]. The counseling
intervention we designed and pilot-tested in this study
addresses these two major barriers. First, it requires very
brief face-to face patient-provider time it so that it can
be delivered during routine office visits for dyslipidemia.
This allows physician to make diet an integral part of
the management strategy for dyslipidemia and cardio-
vascular risk reduction. Second, the physicians’ nutrition
counseling skills are enhanced by standardized written
and web-based tools that allow the physician to provide
patients with pertinent, clearly written dietary advice.
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tion was the paucity of dietary screening questionnaires
that could be used in primary care setting. We deter-
mined that the Rate-your-Plate questionnaire was the
most appropriate tool for this purpose. We made several
changes to the display of the diet scores, in order to
facilitate a faster, easier review of the diet quality. It is
important to note that our modified diet scores had
nearly perfect correlation (Pearson correlation, r = 0.967,
p = 0.0005) with the original scores.
This study has several limitations. First, we assessed
diet changes using only self reported screening methods.
Secondly, the study was only six months in duration.
This relatively short interval of follow up, and the
selection bias of highly motivated volunteers who were
interested in making changes to their diet, could over-
estimate the effect of the intervention on the outcomes.
Also, the physician delivering the intervention developed
it, and was similarly highly motivated. Thus, gene-
ralization of this dietary counseling intervention requires
further assessment in less ideal environments and in a
wider range of patients and providers, with a longer time
of follow-up. A larger sample size would allow for
assessing the effect o the intervention in important sub-
groups of patients (based on socio-economic status, level
of education, age groups, etc.). The current study uses
both paper-based and internet-based counseling mate-
rials, which may be redundant. Additional study arms to
explore the effect of the counseling using paper-based
only and web-based only should be considered in a
future larger sample size study.
Conclusions
Efficient low-intensity dietary counseling provided by
the PCP during routine office visits, as an integrative
part of dyslipidemia treatment, is feasible by using writ-
ten and web-based counseling tools. In this pilot study
we observed clinically meaningful improvements in both
diet and lipids of magnitude similar to changes reported
with high intensity dietary counseling interventions.
Further study in a larger more diverse population and
with longer follow-up is warranted to validate these
preliminary results. Finding efficient low-intensity diet-
ary counseling interventions, sustainable in the current
clinical settings, will help close the gap between clinical
research and clinical practice.
Abbreviations
PCP: Primary care physician; RYP: Rate your plate; BMI: Body mass index.
Competing interests
All the authors declare that they do not have any competing interests.
Authors’ contributions
DK designed the protocol, outlined and develop the content of the
counseling tools, conducted the study, and coordinated the collection theclinical data. DK and RDL analyzed the data. JA and KMG contributed to the
development of dietary assessment and of counseling materials. KS and CF
helped develop the database and interactive web-based counseling system.
All five authors have been involved in drafting the manuscript or revising it
critically for important intellectual content and have given final approval of
the version to be published. All authors read and approved the final
manuscript.
Funding
This project was supported by grants from the NCRR/NIGMS National Center
for Research Resources (5P20RR016464-11) and the National Institute of
General Medical Sciences (8 P20 GM103440-11) from the National Institutes
of Health.
Author details
1Department of Internal Medicine-Reno, University of Nevada School of
Medicine, 1500 E. 2nd Street, Suite #302, Reno, NV 89502, USA. 2Department
of Family Medicine-Las Vegas, University of Nevada School of Medicine, Las
Vegas, NV 89012, USA. 3Jackson Hole Center for Preventive Medicine,
Jackson, WY 83002, USA. 4Department of Agriculture, Nutrition and
Veterinary Science, Dietetic Program, University of Nevada-Reno, Reno, NV
89557, USA. 5Department of Behavioral and Social Sciences, Brown
University, Providence, RI 02912, USA. 6Brown University Institute for
Community Health Promotion, Providence, RI 02912, USA. 7Department of
Biochemistry and Molecular Biology, University of Nevada-Reno, Reno, NV
89557, USA. 8Nevada Bioinformatics Institute, University of Nevada-Reno,
Reno, NV 89557, USA.
Received: 24 December 2012 Accepted: 3 May 2013
Published: 12 May 2013
References
1. Roger VL, Go AS, Lloyd-Jones DM, et al: Heart disease and stroke statistics -
2011 update: a report from the American Heart Association. Circulation
2011, 123(4):e18–e209.
2. Law MR, Wald NJ, Thompson SG: By how much and how quickly does
reduction in serum cholesterol concentration lower risk of ischaemic
heart disease? BMJ 1994, 308:367–372.
3. National Cholesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
(Adult Treatment Panel III): Third Report of the National Cholesterol
Education Program (NCEP) Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel
III) final report. Circulation 2002, 106(25):3143.
4. U.S. Preventive Services Task Force: Behavioral Counseling in Primary Care to
Promote a Healthy Diet in Adults at Increased Risk for Cardiovascular Disease,
Topic Page. 2011. http://www.uspreventiveservicestaskforce.org/uspstf/
uspsdiet.htm.
5. Hsiao CJ, Cherry DK, Beatty PC, et al: National Ambulatory Medical Care
Survey: 2007 summary. Natl Health Stat Report 2010, 27:1–32.
6. Cherry DK, Hing E, Woodwell DA, et al: National Ambulatory Medical Care
Survey: 2006 summary. Natl Health Stat Report 2006, 3:1–39.
7. Linn JS, et al: Behavioral counseling to promote physical activity and a
healthful diet to prevent cardiovascular disease in adults. Ann Intern Med
2010, 153:736–750.
8. Gans KM, Hixson ML, Eaton CE, et al: Rate your Plate: an eating pattern
assessment and educational tool for blood cholesterol control.
Nutr Clin Care 2000, 3:163–169.
9. Gans KM, Sundaram S, Hixson ML, et al: Rate your Plate: an eating pattern
assessment and educational tool used at cholesterol screening and
education programs. J Nutr Educ 1993, 25:29–36.
10. Gans KM, Burkholder GJ Jr, Risica PM, Harrow B, Lasater TM: Cost-
effectiveness of minimal contact education strategies for cholesterol
change. Ethn Dis 2006, 16(2):443–451.
11. Kincaid JP, Braby R, Wulfeck WH II: Computer aids for editing tests.
Educ Technol 1983, 23:29–33.
12. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al: General cardiovascular risk
profile for use in primary care. the framingham heart study. Circulation
2008, 117:743–753.
13. Browne RH: On the use of a pilot sample for sample size determination.
Stat Med 1995, 14:1933–1940.
Kulick et al. BMC Family Practice 2013, 14:59 Page 12 of 12
http://www.biomedcentral.com/1471-2296/14/5914. Råstam L, Hannan PJ, Luepker RV, et al: Seasonal variation in plasma
cholesterol distributions: implications for screening and referral.
Am J Prev Med 1992, 8:360–366.
15. Gordon DJ, Hyde J, Trost DC, et al: Cyclic seasonal variation in plasma
lipid and lipoprotein levels: the lipid research clinics coronary primary
prevention trial placebo group. J Clin Epidemiol 1988, 41:679–689.
16. Hiddink GJ, Hautvast JG, van Woerkum CM, et al: Consumers' expectations
about nutrition guidance: the importance of primary care physicians.
Am J Clin Nutr 1997, 65(6 Suppl):1974S–1979S.
17. Stange KC, Woolf SH, Gjeltema K: One minute for prevention: the power
of leveraging to fulfill the promise of health behavior counseling.
Am J Prev Med 2002, 22:320–323.
18. Yarnall KS, Pollak KI, Ostbye T, et al: Primary care: is there enough time for
prevention? Am J Public Health 2003, 93:635–641.
19. Beasley JW, Hankey TH, Erickson R, et al: How many problems do family
physicians manage at each encounter? A WReN study. Ann Fam Med
2004, 2:405–410.
20. Flynn M, Sciamanna C, Vigilante K: Inadequate physician knowledge of
the effects of diet on blood lipids and lipoproteins. Nutr J 2012, 2:19.
http://www.nutritionj.com/content/2/1/19 (accessed 10 August 2012).
21. Ammerman AS, DeVellis RF, Carey TS, et al: Physician-based diet
counseling for cholesterol reduction: current practices, determinants,
and strategies for improvement. Prev Med 1993, 22:96–109.
doi:10.1186/1471-2296-14-59
Cite this article as: Kulick et al.: Live well: a practical and effective low-
intensity dietary counseling intervention for use in primary care
patients with dyslipidemia - a randomized controlled pilot trial. BMC
Family Practice 2013 14:59.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
